Transport Pharmaceuticals Report issue

For profit Phase 2
Founded: Framingham MA United States (1999)
Status: Acquired by Nitric BioTherapeutics, Inc (2009)

Organization Overview

First Clinical Trial
2007
NCT00469300
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Transport Pharmaceuticals, Inc.

Active Ingredients

Drugs in Phase 2 Trials (1)

aciclovir (zovirax) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Herpes Labialis (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1